Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 331 AL 345

Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer's Disease

Bhatnagar D, Ladhe S, Kumar D.

Mol Neurobiol. 2023 Oct;60(10):5954-5974. doi: 10.1007/s12035-023-03446-0. Epub 2023 Jun 29.

Emerging nanotechnology for Alzheimer's disease: From detection to treatment

Song N, Sun S, Chen K, Wang Y, Wang H, Meng J, Guo M, Zhang XD, Zhang R.

J Control Release. 2023 Aug;360:392-417. doi: 10.1016/j.jconrel.2023.07.004. Epub 2023 Jul 10.

Therapy and diagnosis of Alzheimer's disease: from discrete metal complexes to metal-organic frameworks

García-García A, Rojas S, Rodríguez-Diéguez A.

J Mater Chem B. 2023 Aug 2;11(30):7024-7040. doi: 10.1039/d3tb00427a.

Review of triazole scaffolds for treatment and diagnosis of Alzheimer's disease

Li Q, Qi S, Liang J, Tian Y, He S, Liao Q, Xing S, Han L, Chen X.

Chem Biol Interact. 2023 Sep 1;382:110623. doi: 10.1016/j.cbi.2023.110623. Epub 2023 Jul 13.

Trial of Solanezumab in Preclinical Alzheimer's Disease

Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL, van Dyck CH, Iwatsubo T, Marshall GA, Yaari R, Mancini M, Holdridge KC, Case M, Sims JR, Aisen PS; A4 Study Team.

N Engl J Med. 2023 Sep 21;389(12):1096-1107. doi: 10.1056/NEJMoa2305032. Epub 2023 Jul 17.

Effect of physical activity program applied to patients with Alzheimer's disease on cognitive functions and depression level: a randomised controlled study

Lok N, Tosun AS, Lok S, Temel V, Aydın Z.

Psychogeriatrics. 2023 Sep;23(5):856-863. doi: 10.1111/psyg.13010. Epub 2023 Jul 24.

Neuropsychiatric Symptoms of Alzheimer's Disease: An Anatomic-Genetic Framework for Treatment Development

Nowrangi MA, Outen JD, Kim J, Avramopoulos D, Lyketsos CG, Rosenberg PB.

J Alzheimers Dis. 2023;95(1):53-68. doi: 10.3233/JAD-221247.

Capturing Measures That Matter: The Potential Value of Digital Measures of Physical Behavior for Alzheimer's Disease Drug Development

Bachman SL, Blankenship JM, Busa M, Serviente C, Lyden K, Clay I.

J Alzheimers Dis. 2023;95(2):379-389. doi: 10.3233/JAD-230152.

The Sigma Receptors in Alzheimer's Disease: New Potential Targets for Diagnosis and Therapy

Wang T, Jia H.

Int J Mol Sci. 2023 Jul 27;24(15):12025. doi: 10.3390/ijms241512025.

Technology caregiver intervention for Alzheimer's disease (I-CARE): Feasibility and preliminary efficacy of Brain CareNotes

Rodriguez MJ, Kercher VM, Jordan EJ, Savoy A, Hill JR, Werner N, Owora A, Castelluccio P, Boustani MA, Holden RJ.

J Am Geriatr Soc. 2023 Dec;71(12):3836-3847. doi: 10.1111/jgs.18591. Epub 2023 Sep 14.

Gamma connectivity predicts response to intermittent theta burst stimulation in Alzheimer's disease: a randomized controlled trial

Hoy KE, Emonson MRL, Bailey NW, Rogers C, Coyle H, Stockman F, Fitzgerald PB.

Neurobiol Aging. 2023 Dec;132:13-23. doi: 10.1016/j.neurobiolaging.2023.08.006. Epub 2023 Aug 22.

Current emerging novel therapies for Alzheimer's disease and the future prospects of magneto-mechanical force therapy

Shen Y, Wang M, Li S, Yang J.

J Mater Chem B. 2023 Oct 11;11(39):9404-9418. doi: 10.1039/d3tb01629c.

Remote evaluation of sleep to enhance understanding of early dementia due to Alzheimer's Disease (RESTED-AD): an observational cohort study protocol

Blackman J, Morrison HD, Gabb V, Biswas B, Li H, Turner N, Jolly A, Trender W, Hampshire A, Whone A, Coulthard E.

BMC Geriatr. 2023 Sep 23;23(1):590. doi: 10.1186/s12877-023-04288-0.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias